Augmented Reality and Virtual Reality In Healthcare Market Size, Share and Growth Outlook, 2026

Augmented Reality and Virtual Reality In Healthcare Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Augmented Reality and Virtual Reality In Healthcare Market size is forecast to increase from $6.39 Billion in 2026 to $18.62 Billion in 2034 at a CAGR of 14.3% between 2026 and 2034.

The Augmented Reality and Virtual Reality In Healthcare market report provides detailed analysis and outlook of Augmented Reality and Virtual Reality In Healthcare segments including By Technology (Augmented Reality, Virtual Reality ), By Offering (Hardware, Software, Professional & Managed Services), By Application (Surgery, Medical Training and Education, Patient Care & Rehabilitation Management, Fitness and Wellness Management, Diagnostics and Medical Imaging Visualization, Pharmacy & Drug Discovery Management), By End-User (Hospitals, Clinics, and Surgical Centers, Academic Medical Centers & Research Institutions, Pharmaceutical & Biotechnology Companies, Government & Defense Healthcare Institutions) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Augmented Reality and Virtual Reality in Healthcare Industry Overview

Immersive Technologies Are Transforming Clinical Care and Medical Education

The augmented reality and virtual reality in healthcare industry is rapidly evolving as healthcare providers, medical educators, and technology developers increasingly adopt immersive digital platforms to improve clinical decision-making, patient engagement, surgical planning, and professional training. Advances in computing power, three-dimensional visualization, and medical imaging integration are enabling AR and VR technologies to move beyond experimental applications and become valuable tools in healthcare delivery. The industry is witnessing growing demand for solutions that enhance visualization of complex anatomical structures, improve procedural accuracy, and provide realistic training environments for healthcare professionals. These developments are positioning immersive technologies as an important component of next-generation digital healthcare ecosystems.

Regulatory Activity Supports Broader Clinical Adoption

Regulatory recognition of AR and VR technologies continues to expand, reflecting growing confidence in their clinical utility. The U.S. FDA Digital Health Center of Excellence significantly expanded its list of medical devices incorporating augmented reality and virtual reality technologies, reaching 104 approved or cleared devices. This represents a substantial increase compared with previous years and demonstrates accelerating adoption across healthcare specialties. Nearly 90% of these devices are reviewed through neurology or radiology pathways, highlighting the importance of image-driven clinical planning, diagnostic support, treatment decision-making, and patient education applications. The growing number of regulatory clearances indicates increasing integration of immersive technologies into routine clinical workflows and healthcare delivery systems.

Advanced Visualization and Medical Training Drive Industry Innovation

Product innovation remains a key growth driver within the AR and VR healthcare market. Augmented Reality Software S.L. received regulatory clearance for LAIA XR, a Class II medical device designed for interactive visualization of three-dimensional medical images. The platform supports pre-operative planning through multi-planar reconstruction, quantitative measurement capabilities, and detailed anatomical modeling using computed tomography and magnetic resonance imaging datasets. These capabilities help clinicians improve surgical planning accuracy and patient-specific treatment preparation. The educational segment is also emerging as a major application area for immersive technologies. Ohio University initiated a randomized controlled trial evaluating cinematic virtual reality as an immersive learning tool for medical students studying geriatric care. The study compares clinical skills performance between students receiving VR-based training and those participating in traditional lecture-based education. Such initiatives highlight the growing role of virtual reality in healthcare education, workforce development, and experiential learning, further expanding the use of immersive technologies across the global healthcare sector.
Autism Spectrum Disorder (ASD) Therapeutics Industry Leucovorin Regulatory Update: In March 2026, the FDA approved leucovorin specifically for cerebral folate transport deficiency in patients with a confirmed FOLR1 gene variant, an ultra-rare genetic condition. The FDA emphasized that there is insufficient data to establish efficacy for ASD more broadly, contrasting with earlier public expectations. A study published in JAMA Network Open (May 18, 2026) by UC San Diego researchers found that prescriptions for leucovorin among children with ASD surged by over 2,000% by late 2025, following media and federal attention, despite the lack of large-scale evidence for its use in ASD. Genetic-Based Research Initiatives (April 2026): Researchers at the Medical University of South Carolina (MUSC) are advancing investigations into single-gene causes of severe ASD, such as MEF2C haploinsufficiency. Strategies under development include viral-based gene delivery to restore protein production and RNA-based therapies. These approaches are intended to move into clinical trials, potentially serving as a roadmap for treating other syndromic forms of autism. Clinical Trial Activity: The STAT-2A trial (KZ101) is currently evaluating the safety and preliminary proof of concept of suramin sodium in male children aged 5–14 with ASD. The study utilizes a randomized, double-blind, crossover design to assess physiological impacts and potential changes in synaptic function. Autoimmune Hemolytic Anemia (AIHA) Therapeutics Industry Priority Review for Nipocalimab (April 2026): Johnson & Johnson announced that the U.S. FDA granted Priority Review to the supplemental Biologics License Application (sBLA) for IMAAVY® (nipocalimab-aahu). If approved, it would be the first FDA-approved therapy specifically for wAIHA. Nipocalimab is a monoclonal antibody that blocks the neonatal Fc receptor (FcRn), which reduces circulating IgG autoantibodies. The FDA’s decision was supported by the Phase 2/3 ENERGY trial, which demonstrated durable hemoglobin responses and improvements in patient fatigue. Breakthrough Therapy Designation for Rilzabrutinib (February 2026): The FDA granted Breakthrough Therapy designation to Sanofi’s rilzabrutinib (a reversible Bruton’s tyrosine kinase inhibitor) for the treatment of wAIHA. This designation was based on ongoing data from the LUMINA 2 phase 2b study. Rilzabrutinib aims to address immune-system dysregulation through multi-immune modulation. Fast Track Designation for Gamgertamig (January 2026): The FDA granted Fast Track designation to gamgertamig (OM336), an investigational BCMA- and CD3-directed bispecific antibody, for the treatment of autoimmune hemolytic anemia. Early clinical data indicated efficacy in relapsed/refractory cases, with a design intended to induce T-cell-dependent cytotoxicity while minimizing severe immune activation.

Augmented Reality and Virtual Reality In Healthcare Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Augmented Reality and Virtual Reality In Healthcare market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Treeview Studio, Surgical Theater, XRHealth, Microsoft Corporation (HoloLens), Meta Platforms, Inc., Dassault Systèmes, Siemens Healthineers AG, Medtronic plc, MindMaze, PrecisionOS. The Augmented Reality and Virtual Reality In Healthcare market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Augmented Reality and Virtual Reality In Healthcare industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Augmented Reality and Virtual Reality In Healthcare Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Augmented Reality and Virtual Reality In Healthcare companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Augmented Reality and Virtual Reality In Healthcare markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Augmented Reality and Virtual Reality In Healthcare Market Competitive Benchmarking and Company Analysis

Leading companies in Augmented Reality and Virtual Reality In Healthcare industry include- Treeview Studio, Surgical Theater, XRHealth, Microsoft Corporation (HoloLens), Meta Platforms, Inc., Dassault Systèmes, Siemens Healthineers AG, Medtronic plc, MindMaze, PrecisionOS. The Augmented Reality and Virtual Reality In Healthcare market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Augmented Reality and Virtual Reality In Healthcare Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Augmented Reality and Virtual Reality In Healthcare market remains one of the strongest-performing segments in the country.
The US Augmented Reality and Virtual Reality In Healthcare Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Augmented Reality and Virtual Reality In Healthcare market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Augmented Reality and Virtual Reality In Healthcare industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Augmented Reality and Virtual Reality In Healthcare markets

Canada's strong Augmented Reality and Virtual Reality In Healthcare sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Augmented Reality and Virtual Reality In Healthcare market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Augmented Reality and Virtual Reality In Healthcare Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Augmented Reality and Virtual Reality In Healthcare market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Augmented Reality and Virtual Reality In Healthcare population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Augmented Reality and Virtual Reality In Healthcare industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Augmented Reality and Virtual Reality In Healthcare market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Augmented Reality and Virtual Reality In Healthcare sales through 2034

France Augmented Reality and Virtual Reality In Healthcare companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Augmented Reality and Virtual Reality In Healthcare Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Augmented Reality and Virtual Reality In Healthcare distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Augmented Reality and Virtual Reality In Healthcare Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Augmented Reality and Virtual Reality In Healthcare market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Augmented Reality and Virtual Reality In Healthcare industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Augmented Reality and Virtual Reality In Healthcare industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Augmented Reality and Virtual Reality In Healthcare Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Augmented Reality and Virtual Reality In Healthcare market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Augmented Reality and Virtual Reality In Healthcare market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Augmented Reality and Virtual Reality In Healthcare Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Augmented Reality and Virtual Reality In Healthcare Market Segmentation

By Technology
Augmented Reality
Virtual Reality
By Offering
Hardware
Software
Professional & Managed Services
By Application
Surgery
Medical Training and Education
Patient Care & Rehabilitation Management
Fitness and Wellness Management
Diagnostics and Medical Imaging Visualization
Pharmacy & Drug Discovery Management
By End-User
Hospitals, Clinics, and Surgical Centers
Academic Medical Centers & Research Institutions
Pharmaceutical & Biotechnology Companies
Government & Defense Healthcare Institutions

Top Companies in Augmented Reality and Virtual Reality In Healthcare Industry

Treeview Studio
Surgical Theater
XRHealth
Microsoft Corporation (HoloLens)
Meta Platforms, Inc.
Dassault Systèmes
Siemens Healthineers AG
Medtronic plc
MindMaze
PrecisionOS

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025